Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Bhumi Pednekar: 40kg Weight Loss Without Ozempic Injectables - Featured image
Weight Management

Bhumi Pednekar: 40kg Weight Loss Without Ozempic Injectables

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·January 15, 2026·2 min read

On this page

  • Overcoming Ignored Health Struggles
  • Achieving 40kg Loss Without Injectables
  • Transition to Vegetarianism and Diet Lessons

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Bollywood actress Bhumi Pednekar lost 40kg without Ozempic or injectables, despite constant rumors. She attributes her transformation to disciplined workouts, a balanced vegetarian diet, and recovery from severe dengue. Discover her practical tips for real weight management.

Share

On this page

  • Overcoming Ignored Health Struggles
  • Achieving 40kg Loss Without Injectables
  • Transition to Vegetarianism and Diet Lessons

Bollywood actress Bhumi Pednekar faces ongoing judgment about her dramatic weight loss, with many assuming she used GLP-1 medications like Ozempic or Mounjaro. On Soha Ali Khan's podcast "All About Her," she clarified that women frequently ask if she took these injectables. Bhumi emphasizes she achieved her results naturally, without medical interventions.

Overcoming Ignored Health Struggles

Bhumi debuted in Bollywood with Dum Laga Ke Haisha in 2015. In November 2023, she was hospitalized with dengue, losing 12kg during recovery. She also endured severe hair loss and intense headaches, spending Diwali in pain rather than celebration.

Achieving 40kg Loss Without Injectables

Dismissing extreme rumors—like claims of rib removal—Bhumi credits nearly a decade of consistent effort. Her transformation stems from regular workouts, disciplined eating, and resilience.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play
  • "I lost 40kg and more without injectables," she stated firmly.
  • Focus on sustainable habits over quick fixes.

Transition to Vegetarianism and Diet Lessons

Motivated by moral and sustainability reasons, Bhumi switched to a vegetarian diet. The shift was challenging; once, 120g of protein caused inflammation.

She now caps intake at 60g daily, prioritizing balanced meals:

  • Breakfast: Oats, smoothie bowls, or poha.
  • Lunch/Dinner: Home-style meals with dals, pulses, and sabzi.
  • Add-ons: Cottage cheese, seeds, protein shakes.
  • Cheat meals: Vada pav, chole bhature, pizza.

Through trial and error, she optimized her nutrition for her body. Today, Bhumi maintains a steady workout routine and commits to sustainability causes alongside her fitness.

Source Information

Originally published by News18.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: Ozempic

All Ozempic articles →
Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics
Pharmaceutical Industry News

Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics

Samsung Biologics has announced a major acquisition of PolyPeptide Group AG for $1.8 billion, marking a strategic expansion into the rapidly growing peptide therapeutics market, particularly for GLP-1 drugs.

8 min read

More in Weight Management

Oral GLP-1s for Weight Loss Maintenance: A New Frontier
Weight Management

Oral GLP-1s for Weight Loss Maintenance: A New Frontier

A groundbreaking study reveals that switching to an oral GLP-1 medication like orforglipron can help individuals maintain a significant portion of their weight loss achieved with injectable therapies, offering a new avenue for long-term obesity management.

6 min read
Orforglipron: The New Oral GLP-1 Challenger in Weight Loss
Weight Management

Orforglipron: The New Oral GLP-1 Challenger in Weight Loss

A new daily pill, Orforglipron, is emerging as a significant contender in the weight loss and diabetes management space, offering a potential oral alternative to injectable GLP-1 medications. This article delves into its mechanisms, trial results, and what it means for the future of treatment.

7 min read
New Procedure May Combat Weight Regain After GLP-1s
Weight Management

New Procedure May Combat Weight Regain After GLP-1s

Losing weight with GLP-1 medications like semaglutide and tirzepatide is a significant achievement, but maintaining that loss after stopping treatment presents a major challenge. A new experimental procedure, duodenal mucosal resurfacing (DMR), is showing remarkable potential in helping individuals keep the pounds off.

7 min read
Share this article
  1. Home
  2. Blog
  3. Bhumi Pednekar: 40kg Weight Loss Without Ozempic Injectables
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community